Cobas¿ infinity central lab IT solution Material Number: 07154003001 Calculator/Data Proces...
FDA Device Recall #Z-1368-2019 — Class II — February 4, 2019
Recall Summary
| Recall Number | Z-1368-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 4, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Roche Diagnostics Corporation |
| Location | Indianapolis, IN |
| Product Type | Devices |
| Quantity | 15 units |
Product Description
Cobas¿ infinity central lab IT solution Material Number: 07154003001 Calculator/Data Processing Module, For Clinical Use
Reason for Recall
Using the following versions of cobas infinity software (2.0 thorough 2.5), there is a potential where the results from the first sample subsequent to the bottle change, (when using the Standby bottle function), does not display a quality control (QC) alarm when one should be present. If the QC is out of range on the stand-by bottle and it is not removed from the system, there is a potential that when the status of the Standby bottle changes from the Standby bottle to the Current bottle status, QC alarms will not be displayed next to the sample result.
Distribution Pattern
US Distribution to states of: AL, AZ, CA, GA, IA, MO, NJ, NY, SC, TN and TX.
Lot / Code Information
Software versions 2.0 thorough 2.5 Serial Numbers: 81191 81371 81385 81465 81469 81470 81481 81485 81527 81528 81618 81628 81652 81655 81662
Other Recalls from Roche Diagnostics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1979-2019 | Class II | The Tina-quant lgA Gen.2 is an immunoturbidimet... | Jun 3, 2019 |
| Z-1928-2019 | Class III | cobas p 701 post-analytical units, Part Number ... | Apr 4, 2019 |
| Z-1927-2019 | Class III | cobas p 501 post-analytical units, Part Number ... | Apr 4, 2019 |
| Z-1194-2019 | Class II | Albumin BCP Product Usage: ALBP is an in v... | Mar 18, 2019 |
| Z-1249-2019 | Class II | cobas e 801 immunoassay analyzer | Mar 15, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.